Liposomes for oral delivery of protein and peptide-based therapeutics: challenges, formulation strategies, and advances-Reference-Cited by-同舟云学术

Liposomes for oral delivery of protein and peptide-based therapeutics: challenges, formulation strategies, and advances

Published:2021 Issue: Volume: Page:
ISSN:2050-750X
Container-title:Journal of Materials Chemistry B
language:en
Short-container-title:J. Mater. Chem. B

Author:

Jash Apratim¹²³⁴^ORCID,Ubeyitogullari Ali¹²³⁴^ORCID,Rizvi Syed S. H.¹²³⁴⁵^ORCID

Affiliation:

1. Department of Food Science

2. Cornell University

3. Ithaca

4. USA

5. School of Chemical and Biomolecular Engineering

Abstract

Schematic representation describing the fate of protein/peptide-based therapeutics loaded liposomes from oral administration to site-specific intestinal delivery to circulation.

Funder

U.S. Department of Agriculture

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering,General Chemistry,General Medicine

Link

http://pubs.rsc.org/en/content/articlepdf/2021/TB/D1TB00126D

Reference198 articles.

1. Recent advances with liposomes as pharmaceutical carriers

2. Cell-Sized Liposomes and Droplets: Real-World Modeling of Living Cells

3. Microfluidic methods for forming liposomes

4. Permeation of protons, potassium ions, and small polar molecules through phospholipid bilayers as a function of membrane thickness

5. Effect of cholesterol on the structure of a phospholipid bilayer

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polymer-mediated protein/peptide therapeutic stabilization: Current progress and future directions;Progress in Polymer Science;2024-09

2. Solubilization techniques used for poorly water-soluble drugs;Acta Pharmaceutica Sinica B;2024-09

3. Fine-tuning of membrane permeability by reversible photoisomerization of aryl-azo derivatives of thymol embedded in lipid nanoparticles;Colloids and Surfaces B: Biointerfaces;2024-09

4. Dihydroquercetin-Loaded Liposomes Change Fibrous Tissue Distribution in the Bleomycin-Induced Fibrosis Model;Acta Naturae;2024-08-21

5. Lipid- and polymer-based formulations containing TNF-α inhibitors for the treatment of inflammatory bowel diseases;Drug Discovery Today;2024-08